Pfizer follows Eli Lilly’s lead in direct-to-consumer push
Obesity drugs’ next wave: These companies could snag 20% of GLP-1 market, analysts say
Earnings Watch: More retailers, CrowdStrike, Nvidia — and the ‘most important tech earnings in years?’
Investing legend Howard Marks shares how investors can take advantage of ‘irrational’ markets
Kamala Harris promises an end to the U.S. housing shortage in her ‘opportunity economy’
Cava’s successful steak launch beefs up restaurant chain’s earnings
At Ross, ‘value offers’ worked, but discount retailer sounds cautious for the rest of the year
Intuit stock slips despite upbeat full-year forecast and a pivot toward AI
